(Q34276433)

English

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

0 references

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials (English)

1 reference

Europe PubMed Central

1 August 2017

circulatory system

1 reference

based on heuristic

inferred from title

author name string

Fiona Turnbull

1

1 reference

Europe PubMed Central

1 August 2017

Blood Pressure Lowering Treatment Trialists' Collaboration

2

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

362

1 reference

Europe PubMed Central

1 August 2017

1527-1535

1 reference

Europe PubMed Central

1 August 2017

9395

1 reference

Europe PubMed Central

1 August 2017

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of isolated systolic hypertension: the SHELL study results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A general parametric approach to the meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914739-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(03)14739-3

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34276433&oldid=2098767503"